Literature DB >> 22137437

Animal models of cutaneous and hepatic fibrosis.

Gideon P Smith1.   

Abstract

Fibrosis occurs as a part of normal wound healing. However, excessive or dysregulated fibrosis can lead to severe organ dysfunction and is a feature of a variety of diseases. Due to its insidious onset, fibrosis tends to go undetected in its early stages. This is in part why these diseases remain so poorly understood. Animal models have provided a means to examine these early stages and to isolate and understand the effect of perturbations in signaling pathways, chemokines, and cytokines. Here, we summarize recent progress in the understanding of the molecular pathogenesis of fibrosis, both its initiation and its maintenance phases, from animal models of fibrosis in the skin and liver. Due to these organs' properties, modeling fibrosis in them poses unique challenges. Elegant solutions have therefore been developed for modeling fibrosis in each, and now, great potential for animal models to contribute to our understanding appears scientifically imminent.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22137437     DOI: 10.1016/B978-0-12-394596-9.00011-1

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  2 in total

1.  Anti-fibrosis effects of Huisheng oral solution in CCl4-induced hepatic fibrosis in rat.

Authors:  Wenting Li; Yuanbo Wu; Chuanlong Zhu; Zheng Wang; Rentao Gao; Quan Wu
Journal:  Indian J Pharmacol       Date:  2014 Mar-Apr       Impact factor: 1.200

2.  Mest attenuates CCl4-induced liver fibrosis in rats by inhibiting the Wnt/β-catenin signaling pathway.

Authors:  Wenting Li; Chuanlong Zhu; Yi Li; Quan Wu; Rentao Gao
Journal:  Gut Liver       Date:  2014-05       Impact factor: 4.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.